Riskpilot← Back to searchSign inGet full accessTarsus products AB
ABActiveOrg 5565148870Kavelvägen 4Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19950 employees
Revenue 2024
SEK 192K
+62% vs 2023
EBITDA margin
-324.2%
+59% vs 2023
Equity ratio
98.1%
Financial strength
Net profit 2024
SEK 226K
-82% vs 2023
| Revenue | SEK 192K | +62% |
| EBITDA | SEK -622K | +59% |
| Net profit | SEK 226K | -82% |
| Total assets | SEK 24M | -22% |
| Equity | SEK 23,5M | -22% |
| Employees | 0 | — |
Legal name
Tarsus products AB
Org number
5565148870
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
15 september 1995
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tillverkning och försäljning av frisk-, idrotts-, hälso- och sjukvårdsprodukter samt musik. Bolaget skall även äga och förvalta fastigheter ävensom idka därmed förenlig verksamhet.
Address
Kavelvägen 4
Email
ekonomi@sjobloms.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 115 | 120 | 144 | 119 | 192 |
| Staff expenses | — | — | — | −0 | −93 |
| EBITDA | −1 288 | −2 341 | −1 183 | −1 515 | −622 |
| Depreciation & amort. | −27 | −32 | −28 | −103 | −103 |
| EBIT | −1 315 | −2 373 | −1 211 | −1 618 | −726 |
| Net financials | 2 344 | 26 913 | 41 | 2 924 | 962 |
| Profit before tax | 2 369 | 24 320 | 34 | 1 276 | 226 |
| Tax | −17 | −0 | −0 | — | — |
| Net profit | 2 352 | 24 320 | 34 | 1 276 | 226 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 355 | 36 938 | 34 882 | 30 863 | 23 977 |
| Equity | 4 674 | 28 994 | 29 028 | 30 304 | 23 530 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 6 428 | 6 690 | 5 854 | 559 | 447 |
| Total debt | 6 428 | 6 690 | 5 854 | 559 | 447 |
EBITDA margin
-324.2%
This company
15.8%
Market median
-2152% vs market
20202024
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20202024
Net profit margin
118.0%
This company
8.1%
Market median
+1357% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UG Audit | Audit | 2022 |
OA Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
JM Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tarsus products AB (this company)
Sjöbloms Sjukvårdsutrustning AktiebolagBoard members of Tarsus products AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Gustav Jonsson | Audit | 0 companies |
| Olov Axel Lennart Sjöblom | Chief Executive Officer | 0 companies |
| Jenny Maria Holmström | Chief Auditor | 0 companies |
| Jenny Kristina Engvall Sjöblom | Deputy Board Member | 0 companies |